This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Perspective on Low High-Density Lipoprotein Disorders and Lp(a) Lipoprotein Excess

Robert S. Rosenson, MD

Arch Intern Med. 1996;156(12):1278-1284.

Abstract
Evidence supports the involvement of 2 common dyslipidemias-low high-density lipoprotein disorders and Lp(a) lipoprotein excess—in coronary heart disease. Until clinical trials determine whether specific therapeutic interventions can prevent the occurrence and recurrence of coronary heart disease in patients with these dyslipidemias, the implementation of cholesterol-lowering guidelines can provide a reasonable way to manage low highdensity lipoprotein disorders and to identify specific categories of patients who may be at particularly high risk for premature coronary heart disease. Empiric treatment guidelines are suggested for low high-density lipoprotein disorders and Lp(a) lipoprotein excess in order to foster further discussion and validation by clinical trial data.

(Arch Intern Med. 1996;156:1278-1284)

Author Affiliations
From the Preventive Cardiology Center, Rush-Presbyterian-St Luke's Medical Center, Chicago, lll.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Invited Commentary: Lipoproteins and Dementia--Is It the Apolipoprotein A-I?
Scarmeas
Am J Epidemiol 2007;165:993-997.
ABSTRACT | FULL TEXT  

Regulation of human apolipoprotein A-I gene expression by equine estrogens
Zhang et al.
J. Lipid Res. 2001;42:1789-1800.
ABSTRACT | FULL TEXT  

Non-High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality
Cui et al.
Arch Intern Med 2001;161:1413-1419.
ABSTRACT | FULL TEXT  

Gemfibrozil, nicotinic acid and combination therapy in patients with isolated hypoalphalipoproteinemia: a randomized, open-label, crossover study
Zema
J Am Coll Cardiol 2000;35:640-646.
ABSTRACT | FULL TEXT  

Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population
Bersot et al.
J. Lipid Res. 1999;40:432-438.
ABSTRACT | FULL TEXT  

Defensin Stimulates the Binding of Lipoprotein (a) to Human Vascular Endothelial and Smooth Muscle Cells
Higazi et al.
Blood 1997;89:4290-4298.
ABSTRACT | FULL TEXT  

Lipoprotein Lp(a) Excess and Coronary Heart Disease
Stein and Rosenson
Arch Intern Med 1997;157:1170-1176.
ABSTRACT